Akcea Therapeutics, Inc.
Part of Ionis Pharmaceuticals, Inc.
- UEI
- REAPMHUALJ99
- CAGE
- 897W4
- Primary NAICS
- 325412 Pharmaceutical Preparation Manufacturing
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Corporate family
-
-
Parent
Carlsbad, CA
P8PVTLSDNNS6
-
Parent
Carlsbad, CA
P8PVTLSDNNS6
- SAM.gov registration date
- Website
- ionis.com
- Founded
- 1996
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Information Technology
- Software & Services
- Internet Software & Services
- SIC code
- 73 Business Services
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract vehicles
Contract awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Inotersen 284MG/1.5ML | Veterans Integrated Service Network 10 (VHA) | $128,789 |
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Sobi, Inc. | Waltham, MA | 325412 Pharmaceutical Preparation Manufacturing |
| Biogen U.s. Corporation | Cambridge, MA | 325412 Pharmaceutical Preparation Manufacturing |
| Mirum Pharmaceuticals, Inc. | San Mateo, CA | 325412 Pharmaceutical Preparation Manufacturing |
| Fennec Pharmaceuticals, Inc. | Durham, NC | 325412 Pharmaceutical Preparation Manufacturing |
| Sanofi Genzyme | Cambridge, MA | 325412 Pharmaceutical Preparation Manufacturing |
About the company
Akcea Therapeutics, Inc., doing business as Akcea Therapeutics, is a biotechnology company specializing in RNA targeted therapy. Akcea develops and delivers genetic medicines.
Akcea has provided pharmaceuticals to the Department of Veterans Affairs (VA) through prime federal contract awards. This includes a $128,788.98 firm fixed price delivery order from the VA Veterans Health Administration Veterans Integrated Service Network 10 for INOTERSEN, an injectable medication, to be delivered to a VA facility in Cincinnati, Ohio by April 2020.
Additionally, Akcea holds several federal contract Indefinite Delivery Vehicles (IDVs) to provide pharmaceuticals to the VA. This includes a $15 million Blanket Purchase Agreement for TEGSEDI under the Pharmaceuticals and Drugs schedule, with orders allowed through September 2021. Akcea also holds two Federal Supply Schedule contracts under the VA's Pharmaceuticals and Drugs schedule, allowing orders up to $250,000 and $25,000 respectively, with one expiring in September 2021 and the other which expired in July 2019.
Quick answers
Is Akcea Therapeutics, Inc. registered in SAM.gov?
Akcea Therapeutics, Inc.'s SAM.gov registration expired on February 21, 2020.
Which contract vehicles does Akcea Therapeutics, Inc. hold?
Akcea Therapeutics, Inc. holds a place on 1 federal contract vehicle: FSS-61-IB.
What is Akcea Therapeutics, Inc.'s most recent federal award?
Akcea Therapeutics, Inc.'s most recent federal contract award is Inotersen 284MG/1.5ML (36C25019N0775), from Veterans Integrated Service Network 10 (VHA), on April 9, 2019.
On GovTribe
See Akcea Therapeutics, Inc.'s full federal record
- Federal contract awards
- IDV awards
- Contract vehicles
- Funding analysis by agency, NAICS and set-aside
- Similar vendors